Surbhi Sidana

77PUBLICATIONS
237CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Jul 08, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

|Jul 02, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Apr 04, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Masooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Mar 27, 2026
Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM.

Surbhi Sidana, Yi Lin, Andrew J Cowan

Pageof 13

Frequent Collaborators

23 joint publications

Krina Patel

20 joint publications

Larry D Anderson

18 joint publications

Doris K Hansen

17 joint publications

David Miklos